pharmaceutical investing Neon Therapeutics Completes Enrollment in Phase 1b NT-002 Clinical Trial for Metastatic Non-Small Cell Lung Cancer
SAGA Metals Completes Phase 2 of Major Drill Program at the Radar Project in Labrador-Confirms Extensive Oxide Mineralization in All Drill Locations at Trapper North and South Zones & Provides Corporate Update
